Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section

• Status: Recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Evaluates the effect of hyperbaric subarachnoid bupivacaine at doses of 5 mg vs 10 mg on mean arterial pressure in obese pregnant patients undergoing cesarean section

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Civil de Guadalajara
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Pregnancy ≥37 weeks gestation with single fetus

• Body mass index (BMI) ≥ 30 kg/m2

• Indication of termination of pregnancy via abdominal caesarean section

• Indication of subarachnoid neuraxial block under mixed technique

• Signing of consent under information

Exclusion Criteria:

• Allergy to local anesthetics

• Psychiatric treatment (antidepressants, anxiolytics, antipsychotics)

• Addiction to any type of drug

• Liver, renal, pulmonary or cardiac disease

• High blood pressure

• Type I, II and gestational diabetes

• Diagnostic of non-calming fetal state